Clinical Trial Update: Study of CM310 in Adolescent Subjects With Atopic Dermatis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CM310 for adolescent atopic dermatitis is currently ACTIVE_NOT_RECRUITING, indicating the study is ongoing but not actively …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Atopic Dermatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING